These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9825269)

  • 21. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The intestinal permeation of didanosine from granules containing microspheres using the everted gut sac model.
    da Silva CF; Severino P; Martins F; Chaud MV; Santana MH
    J Microencapsul; 2009 Sep; 26(6):523-8. PubMed ID: 19545225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of oral omeprazole in llamas.
    Poulsen KP; Smith GW; Davis JL; Papich MG
    J Vet Pharmacol Ther; 2005 Dec; 28(6):539-43. PubMed ID: 16343286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: in vitro and in vivo evaluation.
    Kaur A; Jain S; Tiwary AK
    Acta Pharm; 2008 Mar; 58(1):61-74. PubMed ID: 18337208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of stavudine in human serum by on-line solid-phase extraction coupled to high-performance liquid chromatography with electrospray ionization tandem mass spectrometry: application to a bioequivalence study.
    Raices RS; Salvadori MC; de Cassia E Estrela R; de Aquino Neto FR; Suarez-Kurtz G
    Rapid Commun Mass Spectrom; 2003; 17(14):1611-8. PubMed ID: 12845587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of time of food administration on the bioavailability of didanosine from a chewable tablet formulation.
    Knupp CA; Milbrath R; Barbhaiya RH
    J Clin Pharmacol; 1993 Jun; 33(6):568-73. PubMed ID: 8366182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies to improve efficacy and safety of a novel class of antiviral hyper-activation-limiting therapeutic agents: the VS411 model in [corrected] HIV/AIDS.
    De Forni D; Stevens MR; Lori F
    Br J Pharmacol; 2010 Oct; 161(4):830-43. PubMed ID: 20860662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multiple-dose pharmacokinetic interaction study between didanosine (Videx) and ciprofloxacin (Cipro) in male subjects seropositive for HIV but asymptomatic.
    Knupp CA; Barbhaiya RH
    Biopharm Drug Dispos; 1997 Jan; 18(1):65-77. PubMed ID: 9008270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of absorption of didanosine after rectal administration in human immunodeficiency virus-infected patients.
    Wintergerst U; Rolinski B; Sölder B; Bogner JR; Wolf E; Jäger H; Roscher AA; Belohradsky BH
    Antimicrob Agents Chemother; 1999 Mar; 43(3):699-701. PubMed ID: 10049294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study on the pharmacokinetics of chlorzoxazone in healthy Thai volunteers.
    Prompila N; Wittayalertpanya S; Komolmit P
    J Med Assoc Thai; 2007 Jan; 90(1):160-6. PubMed ID: 17621748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zidovudine plus didanosine in primary HIV-1 infection.
    Perrin L; Yerly S; Charvier A; Figueras G; Schockmel GA; Hirschel B
    Antivir Ther; 1997 Jan; 2(1):5-11. PubMed ID: 11322267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationships between half-life (t1/2) and mean residence time (MRT) in the two-compartment open body model.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2004 May; 25(4):157-62. PubMed ID: 15108218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of lamivudine in human plasma by HPLC and its use in bioequivalence studies.
    Kano EK; dos Reis Serra CH; Koono EE; Andrade SS; Porta V
    Int J Pharm; 2005 Jun; 297(1-2):73-9. PubMed ID: 15907596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term anti-HIV activity of the combination of didanosine and hydroxyurea.
    Clotet B; Ruiz L; Cabrera C; Ibáñez A; Cañadas MP; Sirera G; Romeu J; Vila J
    Antivir Ther; 1996 Aug; 1(3):189-93. PubMed ID: 11322253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of microbiologic and high-performance liquid chromatography assays to determine plasma concentrations, pharmacokinetics, and bioavailability of erythromycin base in plasma of foals after intravenous or intragastric administration.
    Lakritz J; Wilson WD; Mihalyi JE
    Am J Vet Res; 1999 Apr; 60(4):414-9. PubMed ID: 10211682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosing-time data used as input to individually parameterized pharmacokinetic models.
    Vrijens B; Tousset E; Rode R; Bertz R; Mayer S; Urquhart J
    J Clin Pharmacol; 2005 Apr; 45(4):461-7. PubMed ID: 15778427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo performance of controlled release pellets of diltiazem HCl.
    Nisarur-ur-Rahman ; K H Y; Jia Woei W
    Pak J Pharm Sci; 2005 Apr; 18(2):44-8. PubMed ID: 16431398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosine.
    Grasela TH; Walawander CA; Beltangady M; Knupp CA; Martin RR; Dunkle LM; Barbhaiya RH; Pittman KA; Dolin R; Valentine FT
    J Infect Dis; 1994 Jun; 169(6):1250-5. PubMed ID: 8195601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.